Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study on Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma.

NCT02063022 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.

NCT NCT02063022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02063022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study on Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma.
Lead sponsor
Italian Sarcoma Group
Phase
Phase 3
Overall status
Completed
Start date
January 22, 2009
Completion date
April 14, 2022
Enrollment
278 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

ewing's sarcoma